Dr. Robert Hauser on the Future of Care

 

Read the Report on Cancer & Aging Learn More About Florida 2030
 
Florida is currently the 3rd largest state in the nation, with approximately 1,100 new people move to Florida EACH DAY. As Florida continues to grow, both in GDP and population, so do new challenges and opportunities. The Florida Chamber Foundation’s Florida 2030 research states that by 2030, nearly 1 out of every 4 Floridians could be over the age of 65. In a report released on the connections of aging and cancer, Cancer Treatment Centers of America estimates that Florida’s elderly population could be five percent larger than the national average.

We caught up with Dr. Rob Hauser, Vice President of Clinical Analytics for Cancer Treatment Centers of America, to discuss Florida’s future challenges and opportunities.


Cancer is the Leading Cause of Death In Florida

Cancer affects us all. But for the more than 325,000 Floridians battling cancer each year, Florida offers an ideal location for treatment. With 720 hospitals, more than 45,000 healthcare centers and designated Cancer Centers of Excellence, patients from all over the world can capitalize on Florida’s oncology expertise and cutting-edge treatment options.

Florida is also a leader in medical innovation, with leading research institutes and R&D establishments developing robotic technology, proton therapy, state-of-the-art radiation systems and drug protocols to treat and cure cancer. With all the improvements to treatment options, can you imagine a future without cancer?

Get Involved:

To add your voice to the conversation on medical innovations and the health of Florida’s population, join the Florida Chamber Foundation’s Health and Wellness Caucus today.

Florida Cancer Center Working to be One of the Top 20 in the U.S.

 $200 Million Investment in Innovation Has Created Some of the Most Advanced Cancer Centers Right Here in Florida

Cancer is one of the leading causes of deaths in Florida. At the University of Miami Sylvester Comprehensive Cancer Center, they are looking to change that. “We have the capability, academics and research that allows us to put together a program that we believe will be as good as any in the United States,” says Dr. Stephen Nimer.
“There should be three national cancer institute designated cancer centers in Florida,” explains Dr. Nimer, speaking of other states in the nation that have roughly one cancer center for every seven million residents. “Florida only has one. These funds are to help Shands Cancer Center and the Sylvester Cancer Center to become NCI-designated. The money is to be used to recruit come of the best cancer researches and physicians in the country, to improve our research capability and our ability to deliver state of the art care.”

The funds Dr. Nimer refers to are the nearly $200 million invested by Governor Rick Scott and the Florida Legislature toward cancer research, including Nautical Cancer Intitule (NCI) – designated cancer centers, which has created some of the most technologically advanced and research forward cancer centers in the nation, right here in Florida. Florida Chamber member Moffitt Cancer Center is currently the only NCI-designated cancer center in the state.

“We have the capability, academics and research that allows us to put together a program that we believe will be as good as any in the United States,” says Dr. Nimer. “At Sylvester, our goal is to be one of the top 20 cancer centers in the United States. And with the support of the governor, the Florida Legislature and the Florida Chamber, we are well on our way to achieving that mission.”

Join the Florida Healthcare Alliance

Learn how Florida’s healthcare innovations are helping to create longer and healthier lives. Email David Christian to join the Florida Chamber’s Healthcare Alliance today.

Dr. Nimer is the Director of the University of Miami Sylvester Comprehensive Cancer Center and a Professor of Medicine, Biochemistry & Molecular Biology. He is an expert in treating leukemia and lymphoma and has dedicated his life to cancer research